Oncolytics Biotech Inc.

(ONC:CA)

By |

Profile

Oncolytics Biotech Inc is a development stage biotechnology company. It focuses on discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its main product is Reolysin. The company also has patents issued worldwide, mainly in US and Canada. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives.

Contact Information

Website: www.oncolyticsbiotech.com
Email: mmoore@oncolytics.ca
Main Phone: +1 403 670-7377
Address: 1167 Kensington Crescent North West
Address 2: Suite 210
State: AB
City / Town: Calgary
Country: CAN
Postal Code: T2N 1X7

Issuer Information

Exchange: TSX
CEO: Matthew C. Coffey
Employees: 23
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.91 $ 0.16 (5.82%)
Last Price 2.91 Change $ 0.16 Change % 5.82 Tick N/A
Bid 2.89 Bid Size 600.00 Ask 2.91 Ask Size 900.00
Open 3.09 High 3.09 Low 2.60 Prev Close 2.75
Last Trade Volume 13,373 52 Wk Hi 10.65 52 Wk Low 2.60
Market Cap 49.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 16,970,187.00 EPS (TTM) -1.10 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 30.86 30.86 3.25 30.86
Low Target Price Estimate 21.37 21.37 2.25 21.37
Mean Target Price Estimate 26.12 26.12 2.75 26.12
Standard Deviation 6.72 6.72 0.71 6.72
Date of Most Recent Estimate 05/14/18 05/14/18 05/14/18 05/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 2